Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data
The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.
Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device
Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.
FDA highlights new Class I recall for Dexcom CGM app
Dexcom recalled its G6 smartphone app after a software error was causing it to stop working with no warning. This is a Class I recall, which means failing to follow the company's instructions could result in a serious adverse event.
Telehealth ketamine service sued after patient dies of overdose
Mindbloom, a telemedicine company that provides ketamine for depression and anxiety as part of a treatment program, is accused of negligence in the death of Philip Ward. But the facts leading up to his overdose are in dispute.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).

old woman or doctor shaking hands with patient

Most adults know nothing about CKM syndrome—but it impacts nearly everyone

Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

Positron emission tomography (PET) nuclear imaging has seen rapid expansion in cardiology and oncology due to its improve accuracy over SPECT and its ability to expand into new areas of cardiovascular imaging. A new review in the American Heart Association journal Stroke outlines another possible use of PET to assess carotid artery atherosclerosis for stroke prevention. Figure courtesy Stroke, https://www.ahajournals.org/doi/10.1161/STROKEAHA.125.050399

PET holds promise for carotid plaque assessments

PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.

heart data research doctor cardiologist AI

New-onset AFib is common after CABG—but typically not persistent or symptomatic

The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.

Hospital in Mexico earns first heart failure certification of its kind

A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM

No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

SGLT2 inhibitors after TAVR may boost survival, limit bioprosthetic valve dysfunction

Prescribing these drugs to TAVR patients could improve certain clinical outcomes, according to a new study of nearly 27,000 adults.

Field Medical FieldForce Ablation pulsed field ablation

Field Medical’s PFA system for ventricular tachycardia shows early potential

More research is still required, but Field Medical's FieldForce Ablation System may represent a significant step forward in the treatment of scar-related ventricular tachycardia.

Clinical

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device

FDA highlights new Class I recall for Dexcom CGM app

Telehealth ketamine service sued after patient dies of overdose

Pulmonary embolism thrombectomy use increases by more than 700%